» Articles » PMID: 14693990

Risk Factors for Myocardial Infarction Case Fatality and Stroke Case Fatality in Type 2 Diabetes: UKPDS 66

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 2003 Dec 25
PMID 14693990
Citations 76
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Patients with diabetes have a higher case fatality rate in myocardial infarction (MI) or stroke than those without diabetes: that is, MI and stroke are more often fatal if diabetes is present. We investigated whether the risk of MI or stroke being fatal in type 2 diabetes can be estimated using information available around the time diabetes is diagnosed.

Research Design And Methods: Analyses were based on 674 cases of MI (351 fatal) that occurred in 597 of 5,102 U.K. Prospective Diabetes Study (UKPDS) patients for whom covariate data were available during a median follow-up of 7 years. Multivariate logistic regression was used to examine differences in risk factors, measured within 2 years of diagnosis of diabetes, between fatal and nonfatal MI. Similar analyses were performed for 234 strokes (48 fatal) that occurred in 199 patients.

Results: Patients with fatal MI had higher HbA(1c) than those with nonfatal MI (odds ratio 1.17 per 1% HbA(1c), P = 0.014). Patients with fatal stroke had higher HbA(1c) than those with nonfatal stroke (odds ratio 1.37 per 1% HbA(1c), P = 0.007). Other risk factors for MI case fatality included increased age, blood pressure, and urine albumin level.

Conclusions: The risk of MI or stroke being fatal in type 2 diabetes is associated with risk factors, including HbA(1c), measured many years before onset of MI or stroke. Equations have been added to the UKPDS Risk Engine to estimate likely case fatality rates in MI and stroke.

Citing Articles

Cardiovascular Outcomes Among Patients with Acute Coronary Syndromes and Diabetes: Results from ACS QUIK Trial in India.

Alfaddagh A, Khraishah H, Romeo G, Kassab M, McMillan Z, Chandra-Strobos N Glob Heart. 2024; 19(1):37.

PMID: 38681971 PMC: 11049669. DOI: 10.5334/gh.1290.


Risk of Stroke in Real-World US Individuals with Type 2 Diabetes Receiving Semaglutide or a Dipeptidyl Peptidase 4 Inhibitor.

Evans M, Husain M, Srivastava A, Mangla K, Kuhlman A, Lingvay I Adv Ther. 2024; 41(5):1843-1859.

PMID: 38340253 PMC: 11052848. DOI: 10.1007/s12325-023-02750-4.


Mesenchymal Stem Cell-Derived Exosomes: A Novel Approach to Diabetes-Associated Cognitive Impairment.

Ran Q, Tian H, Lin J, Wang H, Wang B, Chen Z J Inflamm Res. 2023; 16:4213-4228.

PMID: 37753267 PMC: 10519429. DOI: 10.2147/JIR.S429532.


Prediction of complications in health economic models of type 2 diabetes: a review of methods used.

Li X, Li F, Wang J, van Giessen A, Feenstra T Acta Diabetol. 2023; 60(7):861-879.

PMID: 36867279 PMC: 10198865. DOI: 10.1007/s00592-023-02045-8.


Long-term increase in fasting blood glucose is associated with increased risk of sudden cardiac arrest.

Kim Y, Roh S, Jeong J, Lee H, Min K, Choi Y Cardiovasc Diabetol. 2023; 22(1):38.

PMID: 36805666 PMC: 9940683. DOI: 10.1186/s12933-023-01764-0.